Austin, TX 10/10/2007 9:16:59 PM
News / Finance

Speak with other shareholders about: (OTC: FTFN), (NASDAQ: ALTI), (OTCBB: DNAG), and (OTCBB: PLTG) .

AUSTIN, TX: October 10, 2007 – Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.

----------------------------------------------------------

Chat real-time with other investors about this FTFN news release, by clicking this link: http://www.stockwire.com/FTFN

To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=FTFN

FANTASTIC FUN INC (OTC: FTFN) "Up 100% in morning trading"

FTFN News:

October 8 - Global Profit Technologies, Inc. Has Acquired a Controlling Interest in Fantastic Fun, Inc.

Fantastic Fun, Inc., a Florida corporation (OTC: FTFN), trading on the Pink Sheets ("FTFN") announced today that 24,490,837 shares, or 94.25%, of its outstanding common stock, have been acquired by Global Profit Technologies, Inc. ("GPTI"), a recently formed Nevada Corporation based in Scottsdale, Arizona, from FTFN's majority shareholder, Fantastic Fun, Inc., an Illinois corporation.

Joseph Nemeth, Chairman and Chief Executive Officer of GPTI was quoted as saying, "This is a strategic acquisition for us, and we look forward to working on creating a great value for our shareholders."

FTFN may be affected by some or all of the factors, risks and uncertainties of any newly formed and/or acquired business with many beyond the management of FTFN's control. Except for factual and historical statements contained herein, the statements made in this release constitute forward-looking statements that involve risks and uncertainties.

----------------------------------------------------------

Chat real-time with other investors about this ALTI news release, by clicking this link: http://www.stockwire.com/ALTI

To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=ALTI

ALTAIR NANOTECHNOLOGY (NASDAQ: ALTI) "Up 44.64% in morning trading"

Altairnano is an innovator and manufacturer of advanced novel, ceramic nanomaterials that are used in products that exhibit groundbreaking performance. Altairnano's products address a diverse range of high-growth energy, industrial and pharmaceutical applications within three businesses: the Altair Power & Energy Group, Altair Materials Group and Altair Life Sciences Group. Our goal, or mission statement, is to create and deliver innovative products that improve the quality of life. For more information visit: www.altairnano.com.

ALTI News:

October 9 - AeroVironment, Altair Nanotechnologies, Go Green Holding and Micro-Vett Announce a Successful, Multiple Fast-Charge Demonstration of an All-Electric Delivery Vehicle in Oslo, Norway.

AeroVironment, Inc. (Nasdaq: AVAV), Altair Nanotechnologies Inc. Altairnano' (Nasdaq: ALTI), Micro-Vett, SPA and Go Green Holding AS, today jointly announced the successful public demonstrations of the All-Electric Fiat Dobl to government officials and potential commercial customers in Oslo, Norway. On October 2nd, half-way through an ongoing 60-day demonstration, the Micro-Vett Fiat Dobl, a regular size 5-seat station wagon vehicle, powered by a custom 18 kWh Altairnano high performance NanoSafe battery pack, traveled 300 kilometers (186 miles) in an urban delivery circuit. The custom battery pack was fully recharged in less than ten minutes a total of three times using AeroViroments' high voltage, 125kW rated, rapid charging system. The vehicle will be driven an estimated total of 7,500 kilometers during the 60-day demonstration period, which translates to an annual equivalent use of 45,000 kilometers.

The Fiat Dobl is designed both as a commercial medium-duty transport vehicle, as well as a regular size family car. Micro-Vett has been converting standard vehicles to electric drive for the past 20 years, and today, they have a wide range of passenger and utility vehicles available for sale. Go Green expects to ship up to 20 Micro-Vett vehicles with Altairnano's 18 kWh NanoSafe battery packs to customers in the next several months, and an additional 250 vehicles are planned for shipment in 2008. Altairnano offers a range of NanoSafe battery packs for all-electric vehicles requiring from 10 to 35 kWh of energy storage.

"This alliance of innovative companies is a powerful combination that is committed to providing clean transportation on a global platform," said Asbjorn Slordahl, Go Green Holdings' chief executive officer. "With battery packs from Altairnano, and fast-charge infrastructure from AeroVironment, these roadway-ready, all-electric vehicles converted by Micro-Vett and distributed by Go Green are a powerful example of what happens when you combine the right technology, with the right providers, at the right time."

"This is a key step forward in demonstrating the viability of all-electric vehicles, and the fast charge infrastructure necessary to enable their practical use," said Joe Edwards, vice president and general manager of AeroVironment's Energy Technology Center. "This demonstration proves that the technology to deploy electric vehicles for everyday use is available and ready. Our PosiCharge fast charge technology has demonstrated itself to be reliable for the daily operation of thousands of heavily used, low voltage electric industrial vehicles throughout North America and increasingly in Europe, Australia and Asia. Using PosiCharge to support high voltage electric vehicles is a natural extension."

"This public demonstration in Norway demonstrates another all-electric vehicle platform that is powered by Altairnano's unique lithium Titanate NanoSafe battery pack product line. The NanoSafe battery packs are safe, powerful, fully rechargeable in less than ten minutes with rapid charge systems, have long life and operate in extreme temperatures," said Alan J. Gotcher, Ph.D., Altair Nanotechnologies, Inc.'s president and chief executive officer. "With more than 1,700 electric-powered vehicles in the country, Norway is taking a proactive approach in the adoption of all-electric vehicle technology and products. Our innovative battery technology, which is capable of thousands of re-charge cycles, provides a necessary ingredient for the adoption of EVs around the globe."

"Micro-Vett has been manufacturing electric vehicles since 1987 and so we constantly follow energy accumulation systems evolution, from batteries to fuel cells," said Massimiliano Di Gioia, Micro-Vett Vice President. "Until now we've seen some developments, but Altairnano's fast charge batteries have the potential to revolutionize electric vehicles and also the automotive industry. It was very exciting to see Dobl's charge level indicator going up visibly in Oslo. With Altairnano's fast charge batteries, we can overcome the primary electric vehicle limitation because we can achieve refueling times comparable to those of gasoline-powered vehicles."

----------------------------------------------------------

Chat real-time with other investors about this DNAG news release, by clicking this link: http://www.stockwire.com/DNAG

To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=DNAG

DNAPRINT GENOMICS (OTCBB: DNAG) "Up 24.14% in morning trading"

DNAPrint(TM) Genomics, Inc. (www.dnaprint.com) is a developer of genomics-based products and services in two primary markets: biomedical and forensics. DNAPrint Pharmaceuticals, Inc., a wholly owned subsidiary, develops diagnostic tests and theranostic products (drug/test combinations) using the Company's proprietary ancestry-informed genetic marker studies combined with proprietary computational modeling technology. Computational Biology and Pharmacogenomics services are also offered externally to biopharmaceutical companies. The Company's first theranostic product is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients (with end stage renal disease). Preclinical and clinical development of all the Company's drug candidates will benefit from simulated pre-trials to design actual trials better and are targeted to patients with genetic profiles indicating their propensity to have the best clinical responses. DNAPrint is proud of its continued dedication to developing and supplying new technological advances in law enforcement and consumer ancestry heritage interests. Please refer to www.dnaprint.com for information on law enforcement and consumer applications which include DNAWITNESS(TM), RETINOME(TM), ANCESTRYbyDNA(TM) and EURO-DNA(TM). DNAWitness-Y and DNAWitness-Mito are two tests offered by the Company. The results from these tests may be used as identification tools when a DNA sample is deteriorated or compromised or other DNA testing fails to yield acceptable results.

DNAG News:

October 9 - DNAPrint(R) Genomics and Bioserve Form Strategic Alliance to Provide Clinical Patient Samples Tagged With Genetic Ancestry Data

DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced the formation of a strategic alliance with BioServe to provide biomedical researchers with clinical DNA samples that for the first time will include genetic ancestry data for each sample. With the added dimension of ancestry information to clinical samples, medical researchers will be able to determine whether certain biological markers are artifacts of genetic ancestry or are true markers for a disease or drug response in a disease. To create the genetic ancestry data, DNAPrint Genomics will analyze and categorize BioServe's Global Repository of nearly 600,000 human biological samples using its ANCESTRYbyDNA(TM) validated genetic ancestry test.

"Our relationship with BioServe is highly synergistic. Both companies believe that any epidemiological program will be more productive with access to high quality validated clinical samples that have been effectively categorized across a validated genetic ancestry platform," said Richard Gabriel, CEO and President of DNAPrint Genomics. "By removing the question of ancestry from a clinical sample researchers can more readily evaluate which medicines will produce side effects within certain ethnic groups, and which medicines will work for the widest spectrum of a population."

"Through this partnership with DNAPrint Genomics we can provide the medical research community with the best defined clinical sample set in the world," said Dr. Kevin Krenitsky, CEO of BioServe. "Additionally, we are able to uniquely support the application of our samples with services that include sample extraction and preparation, genotyping, and gene expression. Now that we are able to add the genetic ancestry component to our samples, a new layer of sample data quality and analysis can be provided that was not previously available to researchers."

Both companies are also capable of providing genotyping services, and between the two companies the following platforms are available: Beckman Ultra High Throughput SNP Platform, Illumina SNP Golden Gate, and Sequenom iPLEX. In addition, several gene RNA expression analysis platforms are available including Differential Expression Pattern Display Technology which has an RNA expression sensitivity 10 to 100 times greater than either of Affymetrix or Illumina gene expression profile technologies.

----------------------------------------------------------

Chat real-time with other investors about this PLTG news release, by clicking this link: http://www.stockwire.com/PLTG

To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=PLTG

PLATINA ENERGY (OTCBB: PLTG) "Up 25.64% in morning trading"

Platina Energy Group, Inc. is a diversified exploration and development company. Since its organization in 2005, it has successfully acquired properties in Northeast Tennessee, West Texas, Central Texas and is now expanding into Oklahoma and East Texas. With off balance sheet financing from financial partners, the Company is able to diversify its exposure while building assets and cash flow without on balance sheet debt leverage or shareholder dilution.

PLTG News:

October 9 - Platina Energy Management Announces Acquisition Buying Spree

Platina Energy Group, Inc. (OTCBB: PLTG), (Frankfurt: O5Y.F) is pleased to announce that management will soon be announcing several acquisition prospects under joint venture arrangements with various Investor Groups.

According to Blair Merriam, President and CEO of Platina, 'We have about completed our due diligence on several producing field opportunities in Texas. Our intention is to make offers on these prospects with our joint venture partners providing the project financing allowing Platina to retain a carried interest for facilitating the acquisitions. According to Chip Langston, head of Platina Exploration Corp., a wholly owned subsidiary, our target is to have net interests from these acquisitions that would yield the equivalent of 500-1000 barrels per day of production to Platina by mid 2008.'

Although Platina cannot guarantee all or any of these acquisitions will be possible, management is confident that it will meet its acquisition goals as it has demonstrated in the past, since its inception in 2005.

----------------------------------------------------------

As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.

As the saying goes...follow the money!

To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .

About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .

The Stockwire Group .
512.358.8440 .
info@stockwire.com .